EnginZyme
EnginZyme is a biotechnology company that specializes in biocatalysis.
EnginZyme has raised €39M across 4 funding rounds from 10 investors, most recently a round in Sep 2026. Based in Stockholm, Sweden; founded 2014; active in Software and Healthtech. Data as of 28 Oct 2026.
Total raised
€39M
€38,658,085
Funding rounds
4
Investors
10
distinct backers
Active since
2020-04
latest 2026-09
Funding by year
EUR raised per year · 2026 YTDEnginZyme — funding by year — interactive chart.
Data table
| EnginZyme — funding by year | |
|---|---|
| 2020 | €6.4M |
| 2021 | €4.6M |
| 2022 | €21M |
| 2026 | €6.7M |
Signals
High confidenceRaise-next likelihood10
base rate 30% for Other
- ▼ Raised very recently
- ▼ Down/flat last round
- ▼ Low backer re-investment
Exit likelihood21
base rate 11% (2+ rounds)
- ▲ €30M+ raised
- ▲ 4 rounds raised
- ▲ Recent equity round, but funding momentum is down (may be rescue financing)
Timing: too soon vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
4 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-09-24 | Other | €6.7M | Almi Invest Greentech,Lotus One Investment,Navigare Ventures,other investors,Sofinnova Partners,Stiftelsen Industrifonden+1 more | View deal → |
| 2022-12-19 | Series B | €21M | Almi Invest Greentech,Bunge Ventures,Industrifonden,Navigare Ventures,SEB GreenTech VC,Sofinnova Partners | View deal → |
| 2021-02-11 | Other | €4.6M | Industrifonden | View deal → |
| 2020-04-22 | Series A | €6.4M | Sofinnova Partners | View deal → |
Investors
10Related news
- EnginZyme Raises €21M in Series B Fundingfinsmes.com · 2022-12
- finsmes.com
- finsmes.com
- galvnews.com
Similar companies
same sector or countryGlobal coverage: FundingData